REPROGRAM | REPAIR | REDEFINE
Aging can be redefined. We’re leading the way.
Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.
REPROGRAM | REPAIR | REDEFINE
Aging can be redefined. We’re leading the way.
Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.
Targeting the biology of aging
Aging is the biggest risk factor for most chronic disease. Groundbreaking research has demonstrated that aging is modifiable and caused by a discrete number of biological mechanisms that can be targeted therapeutically. We’re developing innovative therapeutics targeting the biology of aging as a new way to treat aging-related diseases.
Two Core Platforms
Our platforms are based on science from world-leading researchers. They each have the potential to prevent, treat, and/or reverse age-related diseases that currently have little to no therapeutic options.
News
- February 13, 2023
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer - February 9, 2023
Life Biosciences CEO Jerry McLaughlin to Speak at Roadmap to Healthy Longevity International Summit - April 14, 2022
Life Biosciences to Present at Longevity Leaders World Congress 2022 - January 5, 2022
Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Round - September 28, 2021
Life Biosciences Receives Translational Research Funding from Alzheimer's Drug Discovery Foundation
